Grantham, Mayo, Van Otterloo & Co (GMO)’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.37M Buy
158,997
+60,097
+61% +$3.43M 0.02% 274
2026
Q1
$5.87M Buy
98,900
+35,300
+56% +$1.7M 0.02% 300
2025
Q4
$2.49M Buy
63,600
+32,067
+102% +$1.24M 0.01% 394
2025
Q3
$1.27M Sell
31,533
-100,214
-76% -$4.09M ﹤0.01% 437
2025
Q2
$5.01M Sell
131,747
-116,415
-47% -$4.27M 0.02% 295
2025
Q1
$10.6M Buy
248,162
+12,413
+5% +$530K 0.03% 230
2024
Q4
$9.55M Sell
235,749
-220,311
-48% -$9.18M 0.03% 258
2024
Q3
$17.5M Buy
456,060
+79,760
+21% +$3.45M 0.05% 213
2024
Q2
$17.6M Sell
376,300
-154,362
-29% -$7.77M 0.06% 213
2024
Q1
$27.5M Sell
530,662
-232,071
-30% -$10.6M 0.1% 147
2023
Q4
$33.5M Sell
762,733
-57,130
-7% -$2.61M 0.15% 122
2023
Q3
$39M Sell
819,863
-60,778
-7% -$2.75M 0.18% 96
2023
Q2
$33.5M Buy
880,641
+218,908
+33% +$7.91M 0.16% 117
2023
Q1
$23.9M Buy
+661,733
New +$29.2M 0.12% 162
2019
Q1
Sell
-33,040
Closed -$955K 733
2018
Q4
$955K Buy
+33,040
New +$1.42M 0.01% 360
2015
Q3
Sell
-7,840
Closed -$432K 586
2015
Q2
$432K Hold
7,840
﹤0.01% 403
2015
Q1
$438K Buy
+7,840
New +$493K ﹤0.01% 397
2013
Q3
Sell
-43,799
Closed -$3.69M 688
2013
Q2
$3.69M Buy
+43,799
New +$4.06M 0.01% 343

Other funds holding OVV

Grantham, Mayo, Van Otterloo & Co (GMO)'s OVV Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Ovintiv (OVV) stake by 61% in Q2 2026, buying an estimated $3.43M and bringing the position to 158,997 shares worth $8.37M. The position accounts for 0.02% of the portfolio, ranked #274.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OVV in Q2 2013 and has held it in 18 quarters since. The position peaked at $39M in Q3 2023. 593 funds tracked by Wall St. Rank hold OVV as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 158,997 shares of Ovintiv worth $8.37M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 60,097 Ovintiv shares in Q2 2026, an estimated $3.43M.
  • Ovintiv made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #274 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ovintiv in Q2 2013 and has held it in 18 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Ovintiv position peaked at $39M in Q3 2023.
  • 593 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.